CD28-SuperMAB

CD28-SuperMAB Uses, Dosage, Side Effects, Food Interaction and all others data.

CD28-SuperMAB is a humanized anti-CD28 monoclonal antibody designed for treating autoimmune diseases and cancer. After the first human trial, it was withdrawn due to severe toxicity (likely due to lymphopenia and human cytokine release).

Trade Name CD28-SuperMAB
Generic Theralizumab
Theralizumab Other Names CD28-SuperMAB, Theralizumab
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
CD28-SuperMAB
CD28-SuperMAB

Innovators Monograph

You find simplified version here CD28-SuperMAB

*** Taking medicines without doctor's advice can cause long-term problems.
Share